Pharmacology and new perspectives of angiotensin II receptor blocker in prostate cancer treatment.
about
Angiotensin receptor blockers and risk of prostate cancer among United States veteransAnalysis of normal-tumour tissue interaction in tumours: prediction of prostate cancer features from the molecular profile of adjacent normal cells.Clinically relevant doses of candesartan inhibit growth of prostate tumor xenografts in vivo through modulation of tumor angiogenesisMarketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists' arsenal.Onco-nephrology: an appraisal of the cancer and chronic kidney disease links.Effect of an angiotensin II type 1 receptor blocker on caveolin-1 expression in prostate cancer cells.Implications of insulin-like growth factor-I for prostate cancer therapies.Angiotensin inhibition and malignancies: a review.Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1.Expression and function of ATIP/MTUS1 in human prostate cancer cell lines.Phase-II trial of combination treatment of interferon-α, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinoma.Expression and role of the angiotensin II AT2 receptor in human prostate tissue: in search of a new therapeutic option for prostate cancer.
P2860
Q24626548-A2A61127-2859-4588-AB4A-966E7EE90BC8Q33867402-8707FACE-3B2A-4CA4-9B92-C5D386E512E5Q34125083-07037B2A-7DCD-42EE-A9E1-E214CF485B92Q35653603-51E37DAF-B570-41D5-BAA4-E54FABC11A1DQ36801561-5748A90C-B704-4C35-B9B4-B9382E8D03CEQ37180068-286EBB37-1997-464D-B2C4-3EC360E8E361Q37381766-7040B850-8307-4303-B96D-1100524B3508Q37429773-9211AFE1-A9C6-4490-A6A8-B2022F732102Q39340234-04A5DF20-36E8-462A-9D1E-61CD80696EA8Q39670866-08DABAB1-A12E-4C77-8A03-D1241AA7FB20Q43471481-D0CCD7FD-9BC4-4F98-9DB9-E5F5913FAE2FQ43880703-6B1630FC-DC49-46E9-9D51-3FB8FF7A5AC9
P2860
Pharmacology and new perspectives of angiotensin II receptor blocker in prostate cancer treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacology and new perspecti ...... in prostate cancer treatment.
@en
Pharmacology and new perspecti ...... in prostate cancer treatment.
@nl
type
label
Pharmacology and new perspecti ...... in prostate cancer treatment.
@en
Pharmacology and new perspecti ...... in prostate cancer treatment.
@nl
prefLabel
Pharmacology and new perspecti ...... in prostate cancer treatment.
@en
Pharmacology and new perspecti ...... in prostate cancer treatment.
@nl
P2093
P2860
P1476
Pharmacology and new perspecti ...... in prostate cancer treatment.
@en
P2093
Hiroji Uemura
Hitoshi Ishiguro
Yoshinobu Kubota
P2860
P356
10.1111/J.1442-2042.2007.01937.X
P577
2008-01-01T00:00:00Z